<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04046796</url>
  </required_header>
  <id_info>
    <org_study_id>DISCO-TWIN</org_study_id>
    <nct_id>NCT04046796</nct_id>
  </id_info>
  <brief_title>Genetic Causes of Discrepant Clinic in Monogenic Twins</brief_title>
  <acronym>DISCO-TWIN</acronym>
  <official_title>Genetic Causes of Discrepant Clinic in Monogenic Twins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the DISCO-TWIN study (prospective, open-label molecular-genetic study), twin pairs with&#xD;
      one healthy and one affected twin with molecularly undiagnosed diseases will be analysed by&#xD;
      means of omics technologies and/ or re-analysed using existing datasets. Phenotype and omics&#xD;
      data will be shared within the University Hospital Tübingen and with external collaborators&#xD;
      to improve the diagnostic rate of the subjects included in the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of new Candidate Genes</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of new Candidate Genes for complex or serious diseases through a comparative genetic analysis of monozygotic clinically discordant twins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of putative disease causes</measure>
    <time_frame>Day 1</time_frame>
    <description>Number characterizations of the identified putative disease causes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of diagnosis</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of patients receiving appropriate therapy after successful diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of molecular causes of diagnostically unclear rare diseases</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of molecular causes of diagnostically unclear rare diseases</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rare Diseases</condition>
  <condition>Genetic Predisposition to Disease</condition>
  <arm_group>
    <arm_group_label>Healthy twin</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Effected Twin</arm_group_label>
    <description>Twin with unclear rare diseases, clinically characterized in the context of outpatient/ inpatient standard care at the University Hospital Tübingen (UKT) or cooperating location.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>NGS Diagnostic</intervention_name>
    <description>Blood take for genetic diagnostic.</description>
    <arm_group_label>Effected Twin</arm_group_label>
    <arm_group_label>Healthy twin</arm_group_label>
    <other_name>Omics Technology</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sampling for NGS analysis and other omics analysis (transcriptomics, proteomics,&#xD;
      metabolomics), functional cell biology studies (for example in fibroblast cultures).&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Twin pair monozygotic clinically (phenotypic) discordant twins&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Twin pair monozygotic clinically (phenotypic) discordant twins&#xD;
&#xD;
          -  Unclear diagnosis&#xD;
&#xD;
          -  Suspected (mono-)genetic cause of the disease in one twin&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Missing informed consent of both twin/ legal representative&#xD;
&#xD;
          -  No distinct phenotype&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jeannette Hübener-Schmid, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tübingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeannette Hübener-Schmid, Dr.</last_name>
    <phone>+49 7071 29</phone>
    <phone_ext>72276</phone_ext>
    <email>jeannette.huebener@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Dufke, PD Dr.</last_name>
    <phone>+49 7071 29</phone>
    <phone_ext>86413</phone_ext>
    <email>andreas.dufke@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeannette Hübener-Schmid, Dr.</last_name>
      <phone>+49 7071-297</phone>
      <phone_ext>2276</phone_ext>
      <email>jeannette.huebener@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Andreas Dufke, PD Dr.</last_name>
      <phone>+49 7071-297</phone>
      <phone_ext>2190</phone_ext>
      <email>andreas.dufke@med.uni-tuebingen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rare Diseases</keyword>
  <keyword>Genetic Predisposition</keyword>
  <keyword>Omics Technology</keyword>
  <keyword>Next Generation Sequencing (NGS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rare Diseases</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

